The Food and Drug Administration called the shots on Monday when it expanded the emergency use authorization of Pfizer-BioNTech’s booster shot of the COVID-19 vaccine.

With the FDA’s authorization, people who are vaccinated and are at least 12-years-old can receive Pfizer-BioNTech’s booster shot against COVID-19. The booster dose contains the same dosage strength (30-µg) as the dose approved in the primary series and comes a month after the FDA approved it for fully vaccinated 16-year-olds.

Recommended Stories

Pfizer-BioNTech asks FDA to authorize COVID-19 vaccine for children under 5

Pfizer to seek FDA approval for COVID-19 vaccine booster shot

COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October